UT-143
UT-143 is an orally active, selective irreversible covalent antagonist of androgen receptor (AR). UT-143 inhibits the proliferation of AR-positive prostate cancer cells, reduces the weight of androgen target tissues in rats, and suppresses the growth of AR-positive xenograft tumors. UT-143 can be used for the research of prostate cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2698320-33-9
- Formule: C20H17F3N6O4
- Masse moléculaire:462.38
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
UT-143 (10 µM; 16 h) significantly reduces genome-wide chromatin accessibility in 22RV1 prostate cancer cells, decreasing the number of accessible regions from 36141 to 10302[1].
UT-143 inhibits androgen receptor transcriptional activation with an IC50 value of 0.15 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | T1/2 |
|---|---|---|---|
| Rat[1] | 20 mg/kg | p.o. | >12 h |
UT-143 (60 mg/kg; p.o.; daily; 18 days) potently inhibits the growth of AR-positive LNCaP-AR prostate cancer xenografts in intact male NSG mice, achieving over 95% tumor growth inhibition[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male)[1]
-
Dosage:20 mg/kg
-
Administration:p.o.; daily; 13 days
-
Result:Reduced prostate weight to ~200 mg (vehicle control ~400 mg, P<0.01).
Reduced seminal vesicle weight to ~200 mg (vehicle control ~400 mg, P<0.01).
Had no effect on body weight, lean mass, fat mass, or the weights of the heart, kidney, spleen, and thymus.
-
Animal Model:NSG (male)[1]
-
Dosage:60 mg/kg
-
Administration:p.o.; daily; 18 days
-
Result:Achieved greater than 95% tumor growth inhibition, with tumor volume showing a net decrease from baseline over the treatment period.
Chemical Information
-
CAS No. 2698320-33-9
-
Masse moléculaire 462.38
-
Formule C20H17F3N6O4
-
SMILES
N#CC(C=N1)=CN1C[C@@](OCC(C(OC)=O)=C)(C)C(NC2=CN=C(C#N)C(C(F)(F)F)=C2)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
UT-143 Related Classifications
HY-181427 Related Classifications
Powered by Bioz